Evidence map›Paper›PMID 30484907›Full record

ArticleExperimental dermatology2019

Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017.

Eran Shavit, Afsaneh Alavi, Falk G Bechara, Richard G Bennett, Marc Bourcier, Ricardo Cibotti, Steven Daveluy, John W Frew, Amit Garg, Iltefat Hamzavi and 20 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Eran ShavitDepartment of Medicine, Division of Dermatology, Women College Hospital, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-2397-6316
Afsaneh AlaviDepartment of Medicine, Division of Dermatology, Women College Hospital, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-1171-4917
Falk G BecharaDepartment of Dermatology, Dermatologic Surgery Unit, Ruhr-University Bochum, Bochum, Germany.
Richard G BennettDepartment of Dermatology, University of California, Los Angeles, Los Angeles, California.
Marc BourcierDermatology Clinic, Sherbrooke University, Moncton, New Brunswick, Canada.
Ricardo CibottiNational Institute of Arthritis and Musculoskeletal and skin diseases, National Institute of Health, Bethesda, Maryland.
Steven DaveluyDepartment of Dermatology, Wayne State University, Dearborn, Michigan.
John W FrewDepartment of Dermatology, Liverpool Hospital, Sydney, New South Wales, Australia.
Amit GargDepartment of Dermatology, Hofstra Northwell School of Medicine, New Hyde Park, New York.
Iltefat HamzaviDepartment of Dermatology, Henry Ford Hospital, Detroit, Michigan.
Lauren K HoffmanAlbert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
Jenny HsaioRonald Reagan UCLA Medical Center, Santa Monica, California.
Joslyn Sciacca KirbyDepartment of Dermatology, Pennsylvania State, Hershey, Pennsylvania.
Hadar Lev-TovDepartment of Dermatology & Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida.
Erin MartinezSchool of Social Work, Detroit, Michigan.
Robert MichelettiDepartments of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Haley B NaikDepartment of Dermatology, UCSF School of Medicine, San Francisco, California.
Aude NassifInstitut Pasteur, Centre Medical, Paris, France.
Cynthia NicholsonDepartment of Dermatology, Wayne State University, Detroit, Michigan.
Angie Parks-MillerDepartment of Dermatology, Dermatologic Surgery Unit, Ruhr-University Bochum, Bochum, Germany.
Zarine PatelAlbert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
Vincent PiguetDepartment of Medicine, Division of Dermatology, Women College Hospital, University of Toronto, Toronto, Ontario, Canada.
Mayur RameshDepartment of Internal Medicine/Infectious Diseases, Henry Ford Hospital, Detroit, Michigan.
Barry ResnikDepartment of Dermatology & Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida.
Christopher SayedDepartment of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Gregory SchultzInstitute of Wound Research, University of Florida, Gainesville, Florida.
Aamir SiddiquiDepartment of Plastic Surgery, Henry Ford Hospital, Detroit, Michigan.
Jerry TanDepartment of Medicine, University of Western Ontario, Windsor, Ontario, Canada.
Ximena WortsmanDepartment of Dermatology, Institute for Diagnostic Imaging and Research of the Skin and Soft Tissues, University of Chile, Santiago, Chile.
Michelle A LowesThe Rockefeller University, New York City, New York.

Funding

The 3rd annual Symposium on Hidradenitis Suppurativa Advances (SHSA) meetingR13AR074881 · NIAMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KIRBY, JOSLYN S · 2018 to 2018
$20k
NIAMS NIH HHS R13 AR074881
6 · The paper itself

Abstract

The 2nd Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) took place on 03-05 November 2017 in Detroit, Michigan, USA. This symposium was a joint meeting of the Hidradenitis Suppurativa Foundation (HSF Inc.) founded in the USA, and the Canadian Hidradenitis Suppurativa Foundation (CHSF). This was the second annual meeting of the SHSA with experts from different disciplines arriving from North America, Europe and Australia, in a joint aim to discuss most recent innovations, practical challenges and potential solutions to issues related in the management and care of Hidradenitis Suppurativa patients. The last session involved clinicians, patients and their families in an effort to educate them more about the disease.

Indexed as

Dermatologic Surgical ProceduresAnti-Infective AgentsAnti-Inflammatory AgentsBiomedical ResearchComorbidityHidradenitis SuppurativaHumansIncidenceQuality of LifeTumor Necrosis Factor-alphaUltrasonographyAnti-Infective AgentsAnti-Inflammatory AgentsTumor Necrosis Factor-alphahidradenitis suppurativasymposium

Identifiers

PMID30484907
PMCPMC6600821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.